Motility-related protein-1 (MRP-1/CD9) is involved in cell motility. We studied the change in the actin cytoskeleton, and the expression of actin-related protein (Arp) 2 and Arp3 and the Wiskott-Aldrich syndrome protein (WASP) family according to MRP-1/CD9 gene transduction into HT1080 cells. The frequency of cells with lamellipodia was significantly lower in MRP-1/CD9-transfected HT1080 cells than in control HT1080 cells (Po0.0001). MRP-1/CD9 gene transduction affected the subcellular localization of Arp2 and Arp3 proteins. Furthermore, MRP-1/CD9 gene transduction induced a downregulation of WAVE2 expression (Po0.0001). However, no difference was observed in the expression of Arp2, Arp3 or other WASPs. A neutralizing anti-MRP-1/CD9 monoclonal antibody inhibited downregulation of WAVE2 in MRP-1/CD9-transfected HT1080 cells (Po0.0001), and reversed the morphological effects of MRP-1/CD9 gene transduction. Furthermore, downregulation of WAVE2 by transfection of WAVE2-specific small interfering RNA (siRNA) mimicked the morphological effects of MRP-1/CD9 gene transduction and suppressed cell motility. However, transfection of each siRNA for Wnt1, Wnt2b1 or Wnt5a did not affect WAVE2 expression. Transfection of WAVE2-specific siRNA also did not affect expressions of these Wnts. These results indicate that MRP-1/CD9 regulates the actin cytoskeleton by downregulating of the WAVE2, through the Wnt-independent signal pathway.
Introduction
Motility-related protein-1 (MRP-1/CD9), a member of the tetraspanins, is implicated in various biological functions including motility (Miyake et al., 1991; Ikeyama et al., 1993) . Experimental studies have demonstrated that MRP-1/CD9 plays a functional role as a tumor metastatic suppressor. Transfection with MRP-1/CD9 cDNA revealed that cell motility was suppressed in MRP-1/CD9-expressing cells (Ikeyama et al., 1993) . The adenoviral transfection of MRP-1/ CD9 cDNA also suppressed pulmonary metastasis and prolonged the survival of tumor-bearing immunodeficient mice (Miyake et al., 2000) . Furthermore, clinical studies have revealed that a reduced expression of MRP-1/CD9 is associated with nodal metastases and a poor prognosis in cancer patients (Higashiyama et al., 1995; Huang et al., 1998) . However, its biological mechanism in regulating cell motility is still not clearly understood.
Intravasation is considered to be a first step in metastasis (Condeelis et al., 2001) . The reorganization of cortical actin filaments plays an important role in cell motility. The actin-related protein (Arp) 2/3 complex and the Wiskott-Aldrich syndrome protein (WASP) family are involved in the reorganization of cortical actin filaments (Takenawa and Miki, 2001; Vartiainen and Machesky, 2004) . The Arp2/3 complex is composed of two Arps, Arp2 and Arp3, which act as templates for new actin filaments, and five additional subunits called ARPC1-5 (Vartiainen and Machesky, 2004) . The Arp2/ 3 complex-dependent de novo actin nucleation is critical for the rapid formation of actin networks at the leading edge of the cells. The resulting reorganization of the actin skeleton provides the protruve force required for the extension of lamellipodia and filopodia observed during cell movement (Bailly et al., 1999) . Furthermore, the WASP family proteins, including the WASP subfamily (WASP and N-WASP) and the WAVE subfamily (WAVE1, WAVE2 and WAVE3), regulate the activation of the Arp2/3 complex (Takenawa and Miki, 2001) .
To clarify the regulation of motility in tumor cells would be helpful in developing new treatment strategies for cancer patients. Therefore, we performed an experimental study on Arps and WASP family proteins in relation to MRP-1/CD9 gene transduction. Consequently, we found that MRP-1/CD9 gene transduction downregulated WAVE2 expression, and it affected the subcellular localization of the Arp2/3 complex. Furthermore, we studied the relationship between the Wnt signal pathways, including Wnt1, Wnt2b1 and Wnt5a, and WAVE2 expression because we recently found that MRP-1/CD9 gene transduction downregulates these Wnt signal pathways (Huang et al., 2004) .
Results
MRP-1/CD9 gene transduction affects the actin cytoskeleton and the subcellular localization of Arp2 and Arp3 in HT1080 cells We used a human fibrosarcoma cell line HT1080, which is highly motile and has a negative expression of MRP-1/CD9, and two adenoviral vectors, a vector encoding human MRP-1/CD9 (rAd5CAG-MRP-1/ CD9) and a control vector containing the bacterial lacZ gene (rAd5CAG-LacZ), as reported previously (Miyake et al., 2000) . Seventy-two hours after the transfection of MRP-1/CD9 into HT1080 using rAd5CAG-MRP-1/ CD9, we performed real-time quantitative reverse transciption-PCR (RT-PCR) analyses to determine the MRP-1/CD9 gene expression, Western blot analyses to determine the MRP-1/CD9 protein expression and motility assays using Transwell plates to evaluate cell motility. As a result, transfection using rAd5CAG-MRP-1/CD9 was found to effectively restore MRP-1/CD9 expression to suppress cell motility in HT1080 cells, as reported previously (Huang et al., 2004) .
Next we performed immunocytochemical analyses of F-actin, Arp2 and Arp3 to investigate the cell shape and actin cytoskeletons. Lamellipodia was frequently seen in the highly motile control HT1080 cells (Figure 1a) . Furthermore, Arp2 and Arp3 proteins tended to localize in the lamellipodia in control HT1080 cells. In contrast, Arp2 and Arp3 proteins tended to diffusely locate in cells after treatment with rAd5CAG-MRP-1/CD9 (CD9-HT1080) (Figure 1b) . Furthermore, the frequency of cells with lamellipodia was significantly lower in CD9-HT1080 than in the control HT1080 cells (29.77 2.3 vs 77.7712.3%, Po0.0001, Figure 1c) . As a result, the MRP-1/CD9 gene transduction affected the Furthermore, we performed Western blot analyses to evaluate the protein expression of WAVE2, Arp2 and Arp3 according to MRP-1/CD9 gene transduction. MRP-1/CD9 gene transduction downregulated the WAVE2 protein expression (Figure 2b ). However, there was no difference in the protein expression of Arp2 or Arp3.
We next performed immunocytochemical analyses with WAVE2 staining. WAVE2 protein also tended to localize in the lamellipodia in control HT1080 cells (Figure 1a ). In contrast, WAVE2 expression was low in CD9-HT1080 cells (Figure 1b) . Furthermore, the frequency of cells with WAVE2 at the lamellipodia was significantly lower in CD9-HT1080 cells than in the control HT1080 cells (6.172.9 vs 28.275.2%, Po0.0001; Figure 2c ).
Anti-MRP-1/CD9 monoclonal antibody inhibits downregulation of WAVE2 in MRP-1/CD9-transfected cells To confirm whether the MRP-1/CD9 gene negatively regulates WAVE2 expression, we examined the effect of an anti-MRP-1/CD9 monoclonal antibody (mAb), ALB-6, which neutralizes the function of the MRP-1/ CD9 protein (Park et al., 2000) . After transfection of MRP-1/CD9 into HT1080, cells were cultured in media containing 1 mg/ml of ALB-6, or a control mouse IgG. Seventy-two hours after transfection of MRP-1/CD9, real-time quantitative RT-PCR to determine the WAVE2 gene expression, Western blot analyses to determine the WAVE2 protein expression, immunocytochemistry and motility assays were performed, on each group of cells.
Consequently, MRP-1/CD9-transfected HT1080 cells maintained in media containing ALB-6 did not have a decreased gene expression of WAVE2 (0.92170.043-fold) in comparison to the control HT1080 cells (Figure 3a) . Furthermore, the WAVE2 gene expression was significantly higher in ALB-6-treated CD9-HT1080 than in CD9-HT1080 (Po0.0001). Western blot analyses also revealed that ALB-6-treated CD9-HT1080 Immunocytochemical analyses revealed that Arps and WAVE2 protein tended to localize in the lamellipodia in ALB-6-treated CD9-HT1080 cells (Figure 3b ). The frequency of cells with lamellipodia in ALB-6-treated CD9-HT1080 was significantly higher than that in CD9-HT1080 (73.178.8 vs 29.772.3%, Po0.0001) and of the same level as that in the control HT1080 cells (Figure 3c ). Furthermore, in motility assays, the number of cells passing through the membrane into the lower chamber in ALB-6-treated CD9-HT1080 was significantly higher than that in CD9-HT1080 (133.0711.0 vs 83.178.0 at 6 h, Po0.0001; 249.6723.2 vs 171.7712.8 at 12 h, Po0.0001) whereas it was of the same level as that in the control HT1080 cells (Figure 3d ).
Decreasing the WAVE2 expression affects the actin cytoskeleton and suppresses cell motility To confirm the involvement of WAVE2 in the actin cytoskeleton and cell motility, the WAVE2 expression was knocked down by transfection of WAVE2-specific small interfering RNA (siRNA) (WAVE2 siRNA). Seventy-two hours after transfection of WAVE2 siRNA or ScraWA siRNA (control) into HT1080 cells, Western blot analyses to determine the WAVE2 protein 
expression, immunocytochemistry and motility assays were performed on each group of cells.
Consequently, the WAVE2 protein expression in cells after the transfection of WAVE2 siRNA was reduced by 90% of the value in cells after the transfection of ScraWA siRNA (Figure 4a ). Immunocytochemical analyses demonstrated that Arp2 and Arp3 proteins tended to diffusely locate in WAVE2 siRNA-transfected HT1080 cells (Figure 4b ). The frequency of cells with lamellipodia in WAVE2 siRNA-transfected HT1080 cells was significantly lower than that in ScraWA siRNA-transfected HT1080 cells (24.674.3 vs 74.57 10.4%, Po0.0001) (Figure 4c) and of the same level as that in CD9-HT1080 cells. Furthermore, in motility assays, the number of cells passing through the membrane into the lower chamber in WAVE2 siRNAtransfected HT1080 cells was significantly smaller than that in ScraWA siRNA-transfected HT1080 cells (76.076.1 vs 131.2711.9 at 6 h, Po0.0001; 160.07 14.6 vs 244.4726.8 at 12 h, Po0.0001) (Figure 4d) and of the same level as that observed in CD9-HT1080 cells.
Expressions of Wnt1, Wnt2b1 or Wnt5a are not associated with WAVE2 expression We recently found that MRP-1/CD9 gene transduction downregulates several Wnt signal pathways, including Wnt1, Wnt2b1 and Wnt5a (Huang et al., 2004) , and therefore we performed further experiments using the transfection of Wnt1-specific siRNA (Wnt1 siRNA), Wnt2b1 siRNA and Wnt5a siRNA to evaluate the relationship between these Wnt signal pathways and the WAVE2 expression. Control scramble oligonucleotides were used for each siRNA. Seventy-two hours Consequently, the transfection of Wnt1 siRNA, Wnt2b1 siRNA and Wnt5a siRNA effectively downregulated the protein expressions of their target Wnts, respectively ( Figure 5 ). However, no difference was observed in the WAVE2 gene expression (1.04370.039-fold) or the WAVE2 protein expression between Wnt1 siRNA-transfected HT1080 cells and control HT1080 cells (Figure 5a ). In addition, no difference was observed in the WAVE2 gene expression (0.95370.076-fold) or the WAVE2 protein expression between Wnt2b1 siRNA-transfected HT1080 cells and control HT1080 cells (Figure 5b) . Furthermore, no difference was observed in the WAVE2 gene expression (0.8457 0.047-fold) or the WAVE2 protein expression between Wnt5a siRNA-transfected HT1080 cells and control HT1080 cells (Figure 5c ).
On the other hand, there was also no difference in the gene expression of Wnt1 (0.98070.046-fold), Wnt2b1 (0.97470.081-fold) or Wnt5a (1.09470.032-fold) between the WAVE2 siRNA-transfected HT1080 cells and the control HT1080 cells. In addition, there was also no difference in the protein expression of Wnt1, Wnt2b or Wnt5a between WAVE2 siRNA-transfected HT1080 cells and ScraWA siRNA-transfected HT1080 cells (Figure 4a ).
Discussion
Metastasis is a critical biological behavior of malignant tumors, and intravasation is considered to be a first step for metastasis (Condeelis et al., 2001) . The reorganization of actin filaments at the leading edges of the cells is a crucial event in cell motility, and it is regulated by a highly integrated signaling cascade (Takenawa and Miki, 2001; Vartiainen and Machesky, 2004) . This signaling cascade is governed by the Rho family, the WASP family and the Arp2/3 complex. Among the Rho family, RhoA, Rac and Cdc42 play important roles in the reorganization of the cortical actin networks (Hall, 1998) . Through the activation of these members of the Rho family, the WASP family can activate the Arp2/3 complex (Yamaguchi et al., 2000; Vartiainen and Machesky, 2004) . Finally, the Arp2/3 complexdependent de novo actin nucleation is critical for the rapid formation of actin networks and protrusions at the leading edge of the cells. Briefly, Rac regulates the formation of lamellipodia through the activation of WAVE (Miki et al., 1998; Machesky et al., 1999; Eden et al., 2002) . Cdc42 controls the extension of filopodia and microspikes through the activation of WASP (Rohatgi et al., 2000; Yamaguchi et al., 2000) . RhoA controls the assembly of stress fibers resulting in contraction at the rear of the cell to translocate the cell body (Maekawa et al., 1999) . In total, these coordinated reorganizations of actin filaments permit cell migration.
On the other hand, MRP-1/CD9 is a member of the tetraspanins, which are glycoproteins forming multimolecular complexes on the cell surface associating numerous proteins, the 'tetraspanin web' (Berditchevski and Odintsova, 1999; Le Naour et al., 2004) . MRP-1/ CD9 is implicated in various biological functions including cell motility (Miyake et al., 1991; Ikeyama et al., 1993) . Many studies have demonstrated that MRP-1/CD9 plays a functional role as a tumor metastatic suppressor (Higashiyama et al., 1995; Huang et al., 1998; Miyake et al., 2000) . However, the biological mechanism by which it regulates cell motility is still not clearly understood. Therefore, we carried out the present study to understand the mechanism by which MRP-1/CD9 regulates cell motility, which could help in developing new treatment strategies for cancer patients.
The present study has demonstrated that MRP-1/ CD9 gene transduction downregulates the WAVE2 expression in HT1080 cells. Furthermore, the neutralizing anti-MRP-1/CD9 mAb treatment inhibited downregulation of WAVE2 in MRP-1/CD9-transfected HT1080 cells, and reversed the morphological effects of MRP-1/CD9 in immunocytochemical analyses. These results indicate that the MRP-1/CD9 signal is located upstream of the WAVE2-mediated pathway. Although our previous study using microarray assays did not detect this fact (Huang et al., 2004) , this oversight might be partly owing to the fact that the signals of the WAVE2 gene spots were weak in the microarray assays we used. A recent study also reported that the difference in measurement of low-expression genes was considered to contribute to the limited correlation between the results of microarray assays and the true values evaluated by real-time RT-PCR (Zhu et al., 2005) .
Furthermore, the present study has demonstrated that MRP-1/CD9 gene transduction affects the subcellular localization of the Arp2/3 complex in HT1080 cells whereas there was no difference in the protein expression of Arp2 or Arp3. Regarding the cell shape, lamellipodia frequently appeared in high motile parental HT1080 cells. In contrast, the frequency of cells with lamellipodia was significantly lower in MRP-1/CD9-transfected HT1080 cells than in parental HT1080 cells.
The WAVE, also known as Scar, was identified as a downstream effector for Rac-mediated lamellipodia formation (Miki et al., 1998) . The WAVE family proteins consist of three orthologs, WAVE1, WAVE2 and WAVE3. WAVE2 is widely expressed, whereas WAVE1 and WAVE3 are predominantly expressed in the brain (Soderling et al., 2003; Vartiainen and Machesky, 2004) . Furthermore, WAVE2 is involved in various biological functions including cell motility, development and angiogenesis Yan et al., 2003) . WAVE2 is essential for the peripheral ruffles at the leading edge of cells, and it promotes directional cell migration Yamazaki et al., 2003) . WAVE2 silencing by RNA interference on tumor cells dramatically suppressed cell motility and metastasis (Kurisu et al., 2005) . These results indicate that WAVE2 acts as a primary effecter downstream of Rac to induce lamellipodia formation and metastasis Kurisu et al., 2005) .
In general, WAVE2 and N-WASP are widely expressed among WASP family proteins. WAVE2 plays a key role in the formation of lamellipodia downstream of Rac, whereas N-WASP plays a key role in the formation of filopodia downstream of Cdc42 (Takenawa and Miki, 2001 ). The present study revealed that MRP-1/ CD9 gene transduction downregulated WAVE2 expression. The coordinated reorganization of actin filaments is considered to be essential for cells to move. As a result, the downregulation of WAVE2 induced by MRP-1/CD9 gene transduction could disrupt the coordinated reorganization of actin filaments to suppress directional cell migration. In fact, the present study revealed that the downregulation of WAVE2 by RNA interference mimicked the functional effects of MRP-1/CD9 transduction.
However, the molecular mechanism by which MRP-1/CD9 downregulates WAVE2 still remains unclear. We recently found that MRP-1/CD9 gene transduction downregulated the Wnt signal pathways, including Wnt1, Wnt2b1 and Wnt5a (Huang et al., 2004) . However, transfection of each siRNA for Wnt1, Wnt2b1 or Wnt5a did not affect WAVE2 expression. Transfection of WAVE2-specific siRNA also did not affect the expressions of these Wnts. As a result, MRP-1/CD9 was thus considered to regulate cell motility by downregulation of WAVE2, through the Wnt-independent signal pathway.
To date, the MRP-1/CD9 protein is considered to form functional complexes with numerous proteins, including integrins (Berditchevski and Odintsova, 1999; Gutierrez-Lopez et al., 2003) , proteins with Ig domains, such as EWI-2 (Stipp et al., 2001) , CD9P-1 (Charrin et al., 2001 ) and major histocompatibility complex molecules (Zilber et al., 2005) , protein kinase C (Zhang et al., 2001 ) and phosphoinositide 4-kinase (Yauch and Hemler, 2000) . Therefore, MRP-1/CD9 could have multiple biological functions through various signaling pathways, such as integrin-linked kinase and phosphatidyl inositol 3-kinase pathways (Chen et al., 1996; King et al., 1997) . The present study has demonstrated that MRP-1/CD9 regulates the actin cytoskeleton by the downregulation of WAVE2, thus resulting in the suppression of cell motility. However, further investigations are necessary to clarify the molecular mechanism of WAVE2 regulation by MRP-1/CD9.
Materials and methods

Cell lines and cell culture
We used a human fibrosarcoma cell line HT1080 (MRP-1/ CD9-negaitve). It was maintained in RPMI-1640 medium supplemented with 10% fetal calf serum.
Transfection of adenoviral vectors
An E1-deleted replication-deficient recombinant adenoviral vector encoding human MRP-1/CD9 under the control of the human CAG promoter (rAd5CAG-MRP-1/CD9) was constructed using an Adenovirus Expression Vector kit (Takara Biomedicals, Otsu, Japan), as reported previously (Miyake et al., 2000) . In addition, a control adenoviral vector containing the bacterial lacZ gene under the control of the human CAG promoter (rAd5CAG-LacZ) was also constructed. HT1080 was maintained in 10 cm culture dishes at 90% confluency. Infections with rAd5CAG-MRP-1/CD9 or rAd5-CAG-LacZ were performed at an MOI of 30 plaque-forming units per cell in a volume of 200 ml for 2 h incubation. Seventytwo hours after treatment with each adenoviral vector, 2 Â 10 5 cells, one-twentieth of the population maintained in 10 cm culture dishes, were placed into each tube on ice for immunofluorescence staining to evaluate MRP-1/CD9 protein expression in each group of cells, as described previously (Huang et al., 2004) . Simultaneously, other subsequent experiments, including extraction of total RNA, protein sample preparation for Western blot analysis, immunocytochemistry and motility assays, were performed using the remaining cells maintained in 10 cm culture dishes.
Antibodies
We used two mouse anti-human MRP-1/CD9 mAbs, M31-15 and ALB-6. M31-15 was initially developed in our laboratory (Miyake et al., 1991) . ALB-6, a neutralizing mAb, was purchased from Immunotech (Marseille, France) (Park et al., 2000) . A rabbit anti-human WAVE2 polyclonal Ab and a rabbit anti-human Arp3 polyclonal Ab were obtained from Upstate Biotechnology (Lake Placid, NY, USA). A rabbit anti-human Arp2 polyclonal Ab (H-84), a rabbit anti-human Wnt1 polyclonal Ab (H-89), a goat anti-human Wnt5a polyclonal Ab (C-16) and a mouse anti-human actin mAb (C-2) were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA Real-time quantitative RT-PCR Total cellular RNA was extracted using the acid guanidinium thiocyanate procedure. First-strand cDNA synthesis was performed with 5 mg of total RNA using a cDNA synthesis kit (Amersham). To quantify gene expression, TaqMan realtime quantitative PCR was performed with the ABI PRISM 7700 Sequence Detection System using TaqMan Gene Expression Assays probes and TaqMan Universal PCR Master Mix (Applied Biosystems, Foster City, CA, USA). Each sample was run in triplicate, and each PCR experiment included three nontemplate control wells. In addition, triplicate assays were performed with RNA samples isolated from at least two independent experiments. A standard curve for the serial dilutions of cDNA of control HT1080 was similarly generated. The comparative threshold cycle method (Applied Biosystems) was used to calculate the gene expression in each sample relative to the value observed in control HT1080 cells, using glyceraldehyde-3-phosphate dehydrogenase as a control for normalization among samples.
Western blot analysis
Western blot analysis was performed to evaluate the expression of various proteins. Briefly, cells were harvested and resuspended in lysis buffer (62.5 mM Tris-HCl, 2% sodium dodecyl sulfate (SDS), 10% glycerol, 4 M urea). Protein samples (50 mg) were each diluted into a 20 ml solution of lysis buffer and 5% 2-mercaptoethanol (Bio-Rad Laboratories, Hercules, CA, USA) and heated in a water bath at 951C for 5 min. Then, protein extracts were separated by 10% SDS polyacrylamide gel electrophoresis in a vertical-slab gel electrophoresis cell (Bio-Rad). Next, the separated proteins were transferred from gel to nitrocellulose membrane (Hybond-ECL; Amersham) and then blocked in a blocking solution (5% dry milk and 0.2% Tween 20 in phosphatebuffered saline (PBS)) for 1 h. Then, membranes were incubated overnight with the primary antibodies detecting M31-15 (1:100), WAVE2 (1:1000), Arp2 (1:500), Arp3 (1:500), Wnt1 (1:500), Wnt2b (1:100) and Wnt5a (1:100). The membranes were then incubated with HRP-labeled secondary antibodies for 1 h. The proteins were visualized on enhanced chemiluminescence film (Hyperfilm; Amersham) by application of Western blotting detection system (Amersham). Finally, the blots were reprobed using antibodies against actin (1:1000) to ensure equal loading and transfer of proteins.
Immunocytochemistry
Cells grown on dishes were fixed for 10 min in 3.7% paraformaldehyde in PBS. After the cells were incubated with 1% bovine serum albumin in PBS for 30 min, the cells were incubated for 1 h with the primary antibodies detecting WAVE2 (1:1000), Arp2 (1:500) and Arp3 (1:500). Next, the cells were incubated with Texas Red-conjugated anti-rabbit IgG for 1 h. The cells were then incubated with fluorescein phalloidin solution (Molecular Probes, Eugene, OR, USA) for 20 min to visualize F-actin. After the cells were mounted, the fluorescent signals were viewed under confocal microscopy (Radiance 2100, Bio-Rad). A ruffled membrane structure with dense cortical actin was regarded as the lamellipodia. For each determination, the photographs of nine randomly selected fields were analysed. At least three independent experiments were performed for each type of cells.
Motility assay
The motility assay was performed using Transwell plates (polycarbonate membrane, 8 mm pores; Costar, Cambridge, MA, USA). 2 Â 10 5 cells were added to the top chamber, and assays were performed at 371C, 5% CO 2 , for 12 h. Cells passing through the membrane into the lower chamber were counted. Each condition was tested in triplicate per experiment, and each experiment repeated three times with consistent results.
siRNA transfection
The target sequences for WAVE2, Wnt1, Wnt2b1 and Wnt5a siRNA oligonucleotides were designed by siRNA Design Support System (Takara Biomedicals). Scrambled oligonucleotides were also designed for each of the above sequences as negative controls. The sense strand sequences were as follows: WAVE2 siRNA, 5 0 -GCAUCAAGCCUCUAAAGA AdTdT-3 0 ; ScraWA siRNA (a negative control for WAVE2 siRNA), 5 0 -ACCAGCGCUAGUACAUAAAdTdT-3 0 ; Wnt1 siRNA, 5 0 -GAAGGUUCCAUCGAAUCCUdTdT-3 0 ; ScraW1 siRNA (a negative control for Wnt1 siRNA), 5 0 -GCCAUCU CGAGUUAGUCAAdTdT-3 0 ; Wnt2b1 siRNA, 5 0 -CAACUC UCCAGAUUACUGUdTdT-3 0 ; ScraW2 siRNA (a negative control for Wnt2b1 siRNA), 5 0 -AGAUUCCAACCUCAUUC GUdTdT-3 0 ; Wnt5a siRNA, 5 0 -GAAGUCCAUUGGAAUA UUAdTdT-3 0 ; ScraW5 siRNA (a negative control for Wnt5a siRNA), 5 0 -AGAGACUCGAUUAAUGAUUdTdT-3 0 . HT1080 cells were seeded in 6 cm culture dishes 24 h before transfection to reach 50-60% confluency. The siRNA transfection was performed in a total volume of 2.5 ml containing each siRNA (final concentration of 25 nM) and 25 ml of TransIT-TKO Transfection Reagents (Mirus, Madison WI, USA) according to the manufacturer's instructions. The efficiency of each siRNA on protein suppression was ascertained by Western blot analyses, and cell viability was microscopically analysed by a Trypan blue exclusion assay. Seventy-two hours after the siRNA transfection, protein sample preparations for Western blot analyses, immunocytochemistry and motility assays were performed.
Statistical analyses
Data were presented as mean7s.d. Because the distributions of the normalized WAVE2 gene expression (P ¼ 0.8245), frequencies of cells with lamellipodia (P ¼ 0.8011) and cells with WAVE2 expression at the lamellipodia (P ¼ 0.8695), showed normal distributions (Kolmogorov-Smirnov analysis), differences in these data were analysed by analysis of variance with the Bonferroni/Dunn test. A P-value of less than 0.05 was considered to be statistically significant.
